Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Recludix Pharma (United States) | Researchclopedia

Back to institutions

Recludix Pharma (United States)

San Diego, Californiacompany

16

Works

164

Citations

4

h-index

Top Research Topics

Protein Degradation and Inhibitors Multiple Sclerosis Research Studies Chronic Lymphocytic Leukemia Research

Top Researchers

Asunción Moreno Unifor

446 works17,360 citationsh-index: 71

Recent Research

Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers

Richard C. Centore,Luis M. M. Soares,et al.

20251 citations

Chronic Myeloid Leukemia Treatments

Chromatin Remodeling and Cancer

Asthma and respiratory diseases

Genomics and Chromatin Dynamics

Dermatology and Skin Diseases

T-cell and B-cell Immunology

Meta-analysis and systematic reviews

Pancreatic and Hepatic Oncology Research

Microbial Natural Products and Biosynthesis

Jae‐Hong Kim Mount Sinai Hospital

588 works11,587 citationsh-index: 58

Daniel K. Treiber Recludix Pharma (United States)

51 works9,798 citationsh-index: 22

Ajay Nirula Eli Lilly (United States)

85 works6,767 citationsh-index: 32

Peter A. Smith Recludix Pharma (United States)

157 works5,013 citationsh-index: 40

Howard Bregman Recludix Pharma (United States)

58 works3,178 citationsh-index: 27

Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers

Richard C. Centore,Luis M. M. Soares,et al.

20250 citations

Highly Selective and Reversible STAT6 Inhibition Demonstrates Potential for Differentiated Efficacy and Safety Profile in Type 2 Allergic Inflammation

Peter Metz,Howard Bregman,et al.

20252 citations

The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials

Jonathan I. Silverberg,David Rosmarin,et al.

202426 citations

Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers

Richard C. Centore,Luis M. M. Soares,et al.

20241 citations

Inhibitors of the Thioesterase Activity of <i>Mycobacterium tuberculosis</i> Pks13 Discovered Using DNA-Encoded Chemical Library Screening

Inna V. Krieger,Subbarao Yalamanchili,et al.

202412 citations